isabelobrien, Author at European Medical Journal - Page 44 of 70

New MS blood test to launch in Europe

Siemens Healthineers has received CE Mark approval for its test for the management of relapsing multiple sclerosis, allowing it to be launched in Europe.

VML Health's Nichole Davies on the good, the bad and the ugly in women’s health

VML’s Chief Strategy Officer, Nichole Davies, talks about the pharma industry’s role in improving the quality of women’s health worldwide, including why investors need to wake up to women’s health issues.

ViiV's Dr Harmony Garges on making a difference in HIV

Dr Harmony Garges, talks to EMJ GOLD about her decision to join the pharmaceutical industry, treating children with HIV and her views on improving access to HIV treatment.

Almirall's Mercedes Diz on dreaming big and testing your limits

Mercedes Diz, Chief Marketing Officer, Almirall, talks about pushing your limits to achieve your goals and how to be more patient centric.

The word spotlight on a blue background with the 'o' as a spotlight circle

Spotlight: May 2024

Catch up on May’s top pharma news in this monthly round-up. From the latest HCP insights on pharma companies to new investments, there’s plenty to discover.

3D human on blue background

Taking medical education into a new dimension

Learn about how 3D human technology offers pharmaceutical companies a fresh and exciting way to take medical education to new heights.

Picture of a pink illustrated brain on a mint green background

Elon Musk’s Neuralink seeks patients for clinical trial

Neuralink, Elon Musk’s brain chip company, is preparing for the first clinical trial of its implant technology.

a lighthouse shining on a group of people

Reaching healthcare professionals with the latest advances

The journey from approval to patient can be convoluted. How can pharma teams communicate the latest advances to busy healthcare professionals?

FDA nod for Roche and Amgen’s blood testing device

The FDA has granted Breakthrough Device Designation to Roche’s new blood test, developed in collaboration with Amgen, that measures key blood markers of inherited cardiovascular risk.

AZ’s Stefan Woxström on preparing healthcare systems for the future

Stefan Woxström, Senior Vice President Europe and Canada, AstraZeneca, talks about the need for future-proofing healthcare systems, incentivising innovation and reimbursement.